PATENT CLAIM ANALYSIS

Application Number: 15947279
Application Type: Utility
Filing Date: 2018-04
Publication Date: 2018-08
Patent Classification: ["546", "155000"]

Abstract:
A compound of formula (I) or a pharmaceutically acceptable salt thereof, for use in the treatment of multiple myeloma.

Claim (Index 1):
A method of treatment of multiple myeloma comprising administering an effective amount of the compound 4-hydroxy-5-methoxy-N,1-dimethyl-2-oxo-N-[4-(trifluoromethyl)phenyl]-1,2-dihydroquinoline-3-carboxamide or a pharmaceutically acceptable salt thereof to a human in need of such treatment.

Metadata:
- Claim Count in Document: 26.0
- Percentile: 91.0
- Lexical Diversity: 1.04545
- Patent Class: 546.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['15510728', '15525086', '12315779', '12759578', '11513959']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.749787275961861
- 35 USC 102 Novelty (BERT): 0.5424123100862083
- Combined Prediction Score: 0.7290497793742958
- Mean Citation Score: 263.486534
- Max Citation Score: 385.55878
- Similarity Product: 340.5700709031392

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test